Brain Tumor, Glioblastoma Stage 4

Case description

The patient was diagnosed with Grade IV Glioma, affecting multiple regions of the brain. Initial symptoms included headaches and blurred vision that persisted for a year. A head CT on September 6, 2022, revealed a tumor in the right thalamus, causing hydrocephalus. A stereotactic biopsy and ventriculoperitoneal shunt placement were performed on September 7, 2022, confirming a diffuse midline glioma, Grade IV. The initial treatment involved chemoradiotherapy with temozolomide (60/2 Gy) from October 11 to November 21, 2022, followed by six cycles of adjuvant temozolomide. However, imaging in September 2023 indicated disease progression. Subsequently, the patient was started on lomustine and bevacizumab, but further progression was noted after four cycles.

Imaging was performed on 16th July, 2024. The following day, 17th July, 2024, treatment at Rife.fi began.

Precautions

Since the patient has a ventriculoperitoneal (VP) shunt in their head, we contacted the Spooky2 manufacturer to check if it was safe to use the Spooky2 device for treatment. Spooky2 support confirmed that it is safe:

I found out that ventriculoperitoneal (VP) shunt is not an electronic implant. Then it is okay when using our machine for plasma, contact, remote or scalar treatment.

Treatment plan

Together with the patient’s caretakers, we consulted Dr. Bill McGraw, a leading cancer specialist who uses Spooky2 technology. He has developed a cancer treatment protocol and has treated over 300 cancer patients with Spooky2 technology.

Here is an outline of the slightly modified treatment protocol from Dr. Bill McGraw that we planned for the patient:

  • Pretreatment session: Glioblastoma preset
  • Session 1: Rife’s original frequencies
  • Session 2: All glioblastoma programs
  • Session 3: All cancer programs reported by biofeedback
  • Session 4: Cancer Basic 5 (XTRA), Cancer Basic 8 (XTRA), and any remaining programs

Sessions 1 to 4 are to be repeated until all herxheimer reactions disappear.

Treatments

Treatment 1: Pretreatment session, July 17th, 2024

Patient doing treatment while

According to a Medscape article , increasing evidence seems to suggest that cytomegalovirus is shown to cause glioblastoma. During the first session, we ran the preset Cancer (Glioblastoma) (DNA) (P) - JW. This preset targets the following viruses:

  • Cynomolgus cytomegalovirus
  • Cytomegalovirus humanbeta5
  • Human cytomegalovirus (HCMV)
  • Human gammaherpesvirus 4
  • Human herpesvirus 4
  • Leporid herpesvirus 4
  • Macacca mulatta cytomegalovirus
  • Mastomys natalensis cytomegalovirus
  • Murid gammaherpesvirus 4
  • Papiine betaherpesvirus 4
  • Saimiriine herpesvirus 4

We ran the preset using Spooky2 Phanotron Plasma Tube and Spooky2 Ultrasonic connected to Spooky2 Central. The treatment duration was 1 hour 30 minutes.

After the treatment, the patient felt very tired. The patient slept till very late the following day.

Two days after the treatment, the patient reported that he had an oral herpes outbreak on his lips. It healed very quickly, within two days, which was very unusual. Usually most outbreaks would take several weeks for him to heal. This was likely a die-off reaction of the herpes virus.

Treatment 2: Rife’s original frequencies, July 22nd, 2024

During this treatment, we ran two different presets simultaneously on two different generators:

  1. Cancer Advanced Preset (P) - JW
    • Using Spooky2 Phanotron Plasma Tube and Spooky2 Ultrasonic connected to Spooky2 Central.
    • The Phanotron Plasma Tube was slightly above his right side ear with the plasma tube pointing towards his head.
  2. Cancer (C) - JW
    • The contact treatment was done using TENS pads that were placed on the patient’s shoulders.

Both presets were used for approximately 1 hour and 5 minutes. Shortly afterward, the patient reported a mild headache. As a precaution, we decided to discontinue the treatments for the day. The headache was initially constant and persisted throughout the 60-minute car ride home, with the pain occurring only when the patient turned their head.

After the treatment, the patient experienced significant fatigue and slept until late the next day. In the following days, he also reported some lower back pain around the kidney area.

Treatment 3: Rife’s Original Frequencies, July 25th, 2024

During this session, we continued the previous programs that were not completed last time. These included Cancer Advanced Preset (P) - JW and Cancer (C) - JW. The patient reported an itch in his right ear 15 seconds after the Spooky2 software switched to frequency 17033662 for the plasma treatment. Because of this, we decided to run this frequency again at the end of the session. The total treatment time was about 1 hour and 30 minutes, using both plasma and contact methods.

Right after the treatment, the patient did not experience any side effects or headaches, unlike the previous session. The next day, he slept until very late.

We also started the Cancer Cell Repair Octave (XTRA) program on Spooky2 Remote with the Healing (R) - JW preset. Since the patient will be traveling overseas for additional treatments, this preset will continue running during his trip.

Treatment 4: Glioblastoma Frequencies, August 6th, 2024

There was a one-week break in the patient’s treatments because he was traveling overseas for additional treatments.

For this session, we created a custom treatment program using all the frequencies from the Spooky2 database related to “glioblastoma.” The programs we used were:

  • Cancer Glioblastoma Tremor (CAFL)
  • Cancer Glioblastoma (CAFL)
  • Giant Cell Glioblastoma (ETDF)
  • Glioblastoma Multiforme (ETDF)
  • Glioblastoma, Retinal (ETDF)
  • Glioblastoma (ETDF)
  • Tumor Brain 2 (XTRA)
  • Tumor Brain 3 (XTRA)
  • Tumor Brain 5 (XTRA)
  • Tumor Brain (CAFL)

We removed any duplicate frequencies. The total treatment time for all these programs was 2 hours and 27 minutes. During the session, the patient did not report any discomfort nor side effects. The next day, he slept until very late.

We also used the Blood Cleanser Cancer program with the Spooky2 Cold Laser. Each run of this program takes 21 minutes, and we ran it 5 times.

The Cancer Cell Repair Octave (XTRA) program on Spooky2 Remote continues to provide remote treatment around the clock.

Treatment 5: Biofeedback scan, August 9th, 2024

At the start of this session, we conducted a biofeedback scan using Spooky2 Scalar. We positioned the patient between the two scalar boxes, ensuring his head was centered between them. During the scan, we asked the software to identify the 20 frequencies that resonated the most. These frequencies were:

  • 589.09508299 Hz
  • 522.48830423 Hz
  • 42672.17232627 Hz
  • 8524.95987167 Hz
  • 8561.26350394 Hz
  • 17088.59689823 Hz
  • 504.89822781 Hz
  • 519.6228639 Hz
  • 501.37672004 Hz
  • 502.12925532 Hz
  • 631.17235956 Hz
  • 506.79491315 Hz
  • 618.21208092 Hz
  • 17054.45812175 Hz
  • 513.42542319 Hz
  • 18054.67256518 Hz
  • 599.3438335 Hz
  • 586.01082258 Hz
  • 510.86502245 Hz
  • 512.78412247 Hz

Initially, a reverse lookup with a match tolerance of 0.0125% didn’t produce any notable results. We then increased the match tolerance to 0.15% and performed the reverse lookup again. Based on this, we chose the most appropriate programs for today’s treatment, which included:

  • Cancer Additional Frequencies 1 (CAFL)
  • Cancer General 3 (CAFL)
  • Giant Cell Glioblastoma (ETDF)
  • Glioblastoma (ETDF)
  • Glioblastoma Multiforme (ETDF)
  • Glioblastoma, Retinal (ETDF)

Today’s treatment lasted for 2 hours and 36 minutes. The biofeedback scan itself took about 10 minutes, and analyzing the results took an additional 20 minutes.

As in the previous session, we also used the “Blood Cleanser Cancer” program with the Spooky2 Cold Laser.

Treatment 6: Cancer Basic 5 (XTRA), Cancer Basic 8 (XTRA), August 14th, 2024

Today we ran the following two programs:

  • Cancer Basic 5 (XTRA)
  • Cancer Basic 8 (XTRA)

These two programs are often found in cancer patients. At the end of the session we also ran a few frequencies from Cancer Basic 6 (XTRA) as it was also repoted in the previous session’s biofeedback scan.

The patient had a slight headache towards the end of the session which went away within 5-10 minutes.

Treatment 7: Rife’s original frequencies, August 22nd, 2024

After completing a full set of all designed treatment protocols, we restarted from the beginning again. Today we ran Rife’s original frequencies by applying Cancer Advanced Preset (P) - JW preset using the Spooky2 Phanotron Plasma Tube. For contact treatment we applied Cancer (Glioblastoma) (DNA) (C) - JW preset near the stomach area.

Patient felt a slight headache during the treatment. After the treatment, he appeared very sleepy.